Delighted our work using aneuploidy as a biomarker of colorectal cancer risk in inflammatory bowel disease is out: https://gut.bmj.com/content/early/2025/01/29/gutjnl-2024-333353

The initial reaction from patients&families has been overwhelming

Led by Ibrahim AlBakir @yosoykit.bsky.social @cancerresearchuk.org @icrlondon.bsky.social